Michael Hennig

Michael Hennig

Company: leadXpro

Job title: Chief Executive Officer


Structure Based Drug Discovery on Membrane Proteins at leadXpro 9:30 am

Discovery of novel small molecule binding sites to activate Kv3.1, TRPV4 Time resolved X-ray crystallography on GPCR’s to investigate structural dynamics of ligand binding Nanobodies and Pro-Macrobodies to facilitate structure determinationRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.